Effect of Some Drugs on Rheumatoid Arithritis Activity

Sherief Abd-Elsalam

Status and phase: Enrolling; Phase 3

Conditions: Rheumatoid Arthritis

Treatments: Drug: Montelukast; Drug: Rupatadine

Study type: Interventional

Funder types: Other

Identifiers

NCT03770923

Rheumatoid Arithritis

Details and patient eligibility

About

Effect of Some Drugs on Rheumatoid Arithritis Activity.

Full description

The study aims at evaluating the effect of Some Drugs on Rheumatoid Arithritis Activity.

Enrollment: 75 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Rheumatoid arthritis

Exclusion criteria

• liver or renal disease

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

75 participants in 3 patient groups

No intervention

No Intervention group

Description:

No intervention

Rupatadine

Active Comparator group

Description:

Rupatadine 10 mg once daily.

Treatment:

Drug: Rupatadine

Montelukast

Active Comparator group

Description:

Montelukast 10 mg daily

Treatment:

Drug: Montelukast